Pharmaceutical Octave capsule listing application accepted into the 6 billion market

Pharmaceutical Network May 27 - On May 26, Stone Pharmaceutical Group submitted an application for listing of class 4 generic drugs in oseltamie capsules to be approved by CDEOseltamivir is a specific inhibitor that acts on neuraminidase to inhibit the development of influenza viruses from their host cells, thereby inhibiting the spread of influenza viruses in the human body to treat influenzathe original manufacturer of Oseltamivir is Roche, the product named Duffy, in 2001 Oselbev capsule swashes were approved in the country; In 2005 and 2006, Roche authorized Oselbev to Shanghai China-West 3D Pharmaceuticals, Dongsun Pharmaceuticals production, respectively, with the name of the commodity , Alfie and Covey? listed for saleAnd the three-dimensional pharmaceutical production of the Chinese and Western Odysone as the government'smedicine, is not in circulation in the market, so the current domestic Oseltamiwe market East Sunshine a uniqueEast Sunshine Pharmaceuticals 2019 financial results show that the total sales of The Vigrog and The Vier capsules reached 5.93 billion yuan, accounting for 95.33% of the company's total turnoverAmong them, the granules are the exclusive dosage forms of Dongsun medicine, approved in 2008, the current market of granulated dosage only East Sunshine pharmaceutical only one obtained production approval, patent protection period until 2026In 2019, the sales of Kwiat particles were well above the amount of 4.27 billion yuan for capsules and 1.66 billion yuan for capsulesInsight database shows that the current domestic listed Oselavir capsule sinforms reached 3, respectively, Xintai Pharmaceuticals, Chengdu Perteand and Shipharmaceutical GroupIn addition, sixare undergoing BE trials(Photo Source: Insight)in addition to the capsule form, Xintai Pharmaceuticals and Chengdu Cente also filed a listing application for oseltamivir cosuspenders phosphateAs can be seen, this annual sales of nearly 6 billion yuan of heavy-duty varieties are about to usher in a number of competitors.